These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12741725)

  • 21. Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in Quinolone-resistant Shigella dysenteriae serotype 1 clinical isolates from Kolkata, India.
    Dutta S; Kawamura Y; Ezaki T; Nair GB; Iida K; Yoshida S
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1660-1. PubMed ID: 15793166
    [No Abstract]   [Full Text] [Related]  

  • 22. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations.
    Kehrenberg C; de Jong A; Friederichs S; Cloeckaert A; Schwarz S
    J Antimicrob Chemother; 2007 May; 59(5):886-92. PubMed ID: 17369276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluoroquinolone resistance in Streptococcus pyogenes.
    Richter SS; Diekema DJ; Heilmann KP; Almer LS; Shortridge VD; Zeitler R; Flamm RK; Doern GV
    Clin Infect Dis; 2003 Feb; 36(3):380-3. PubMed ID: 12539083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutant prevention concentrations for single-step fluoroquinolone-resistant mutants of wild-type, efflux-positive, or ParC or GyrA mutation-containing Streptococcus pneumoniae isolates.
    Smith HJ; Walters M; Hisanaga T; Zhanel GG; Hoban DJ
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3954-8. PubMed ID: 15388458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid assay for detecting gyrA and parC mutations associated with fluoroquinolone resistance in Enterobacteriaceae.
    Nakano R; Okamoto R; Nakano A; Nagano N; Abe M; Tansho-Nagakawa S; Ubagai T; Kikuchi-Ueda T; Koshio O; Kikuchi H; Ono Y
    J Microbiol Methods; 2013 Sep; 94(3):213-6. PubMed ID: 23816531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quinolone resistance mutations in Streptococcus pneumoniae GyrA and ParC proteins: mechanistic insights into quinolone action from enzymatic analysis, intracellular levels, and phenotypes of wild-type and mutant proteins.
    Pan XS; Yague G; Fisher LM
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3140-7. PubMed ID: 11600369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An extended PCR-RFLP assay for detection of parC, parE and gyrA mutations in fluoroquinolone-resistant Streptococcus pneumoniae.
    Alonso R; Galimand M; Courvalin P
    J Antimicrob Chemother; 2004 Apr; 53(4):682-3. PubMed ID: 15014061
    [No Abstract]   [Full Text] [Related]  

  • 28. [Quinolone].
    Sato K; Tanaka M
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():227-33. PubMed ID: 12717976
    [No Abstract]   [Full Text] [Related]  

  • 29. Mutational paths towards increased fluoroquinolone resistance in Legionella pneumophila.
    Almahmoud I; Kay E; Schneider D; Maurin M
    J Antimicrob Chemother; 2009 Aug; 64(2):284-93. PubMed ID: 19474069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance to fluoroquinolones by the combination of target site mutations and enhanced expression of genes for efflux pumps in Shigella flexneri and Shigella sonnei strains isolated in Korea.
    Kim JY; Kim SH; Jeon SM; Park MS; Rhie HG; Lee BK
    Clin Microbiol Infect; 2008 Aug; 14(8):760-5. PubMed ID: 18727800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-level fluoroquinolone resistance in a clinical Streptoccoccus pyogenes isolate in Germany.
    Reinert RR; Lütticken R; Al-Lahham A
    Clin Microbiol Infect; 2004 Jul; 10(7):659-62. PubMed ID: 15214881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance.
    Akasaka T; Tanaka M; Yamaguchi A; Sato K
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2263-8. PubMed ID: 11451683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates.
    Bansal S; Tandon V
    Int J Antimicrob Agents; 2011 Mar; 37(3):253-5. PubMed ID: 21236644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa.
    Kugelberg E; Löfmark S; Wretlind B; Andersson DI
    J Antimicrob Chemother; 2005 Jan; 55(1):22-30. PubMed ID: 15574475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid detection of gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae by denaturing high-performance liquid chromatography.
    Shigemura K; Shirakawa T; Okada H; Tanaka K; Udaka T; Kamidono S; Arakawa S; Gotoh A
    J Microbiol Methods; 2004 Dec; 59(3):415-21. PubMed ID: 15488283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China.
    Pu XY; Pan JC; Wang HQ; Zhang W; Huang ZC; Gu YM
    J Antimicrob Chemother; 2009 May; 63(5):917-20. PubMed ID: 19297378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo pharmacodynamic efficacy of gatifloxacin against Streptococcus pneumoniae in an experimental model of pneumonia: impact of the low levels of fluoroquinolone resistance on the enrichment of resistant mutants.
    Croisier D; Etienne M; Piroth L; Bergoin E; Lequeu C; Portier H; Chavanet P
    J Antimicrob Chemother; 2004 Sep; 54(3):640-7. PubMed ID: 15317743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of a new mutation in parE to quinolone resistance in extended-spectrum-beta-lactamase-producing Escherichia coli isolates.
    Sorlozano A; Gutierrez J; Jimenez A; de Dios Luna J; Martínez JL
    J Clin Microbiol; 2007 Aug; 45(8):2740-2. PubMed ID: 17567787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
    Turner AK; Nair S; Wain J
    J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of isolation of fluoroquinolone-resistant Ureaplasma urealyticum and identification of mutant sites.
    Zhang W; Wu Y; Yin W; Yu M
    Chin Med J (Engl); 2002 Oct; 115(10):1573-5. PubMed ID: 12490114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.